ArticleBMJ open respiratory research2025

Multicentre controlled open randomised clinical trial to assess efficacy and safety of an anti-tuberculosis drug combination based on optimised-dose rifampicin, optimised-dose moxifloxacin and optimised-dose linezolid for TB: the RML-TB trial protocol.

Laura Diab Casares et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.